Home > Healthcare > Medical Devices > Diagnostic Devices > Urinary Tract Infection Testing Market
Urinary Tract Infection Testing Market Size
Urinary Tract Infection Testing Market size was valued at over USD 590 million in 2022 and is slated to exhibit more than 5.7% CAGR from 2023 to 2032 driven by increasing prevalence of urinary tract infections globally.
Urinary tract infection (UTI) testing is a diagnostic process used to detect the presence of bacteria or other pathogens in a patient's urine that may be causing an infection in the urinary tract. UTIs are a common infection, particularly among women, and can cause discomfort, pain, and other health complications if left untreated. Additionally, the high prevalence of diabetes is further accelerating market statistics.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 592 Million |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 5.7% |
| 2032 Value Projection: | USD 1 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 200 |
| Tables, Charts & Figures: | 357 |
| Segments covered: | Test type, Test kit type, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Moreover, in 2021, as per statistics provided by the International Diabetes Federation (IDF), about 537 million adults aged between 20-79 years lived with diabetes. Furthermore, the high number of type 1 diabetes patients mainly children and adolescents will further propel the market growth since diabetic patients are highly prone to contract UTI. In addition, several market players are emphasizing on research and development activities for the development of novel urinary tract infection testing devices such as test strips.
COVID-19 Impact
The recent outbreak of COVID-19 had a moderately negative impact on entire point of care testing industry. While the demand for UTI testing remains relatively stable, the pandemic caused disruptions in the supply chain and reduced access to testing facilities. Furthermore, the pandemic disrupted the supply chain for UTI testing products, including laboratory equipment and reagents. The closure of borders, restrictions on international travel, and supply chain disruptions made it challenging for companies to obtain the necessary raw materials and supplies to manufacture UTI testing products.
Also, the pandemic led to a reduction in the number of visits to healthcare facilities for non-COVID-19 related issues, including UTI testing. Patients were hesitant to visit healthcare facilities due to the risk of exposure to the virus, leading to a decrease in the number of UTI tests performed.
Urinary Tract Infection Testing Market Trends
Prominent industry players are continuously focusing on product innovation with integration of advanced technologies. Such developments are aimed towards offering simplified and convenient diagnostic test types. Innovations in test kit types will have a positive impact on urinary tract infection testing business expansion. For instance, in August 2022, TestCard announced the launch of a non-invasive home testing kit in UK for the detection of UTI. In addition, it is a smartphone enabled UTI test that allows users to detect UTI through immediate testing results.
Urinary Tract Infection Testing Market Analysis
The urinary tract infection testing market is segmented by test type into urinalysis, urine cultures, and susceptibility testing. The urinalysis segment held the largest revenue size over USD 270 million in 2022 and is estimated to reach more than USD 470 million by 2032. The increasing ageing population base is anticipated to cause a growth in the demand for urinalysis during the forecast period. Urinary tract infections are more common in the elderly population.
A urine analysis examines the urine sample's chemical, visual, and microscopic components. Healthcare professionals are increasingly using urinalysis to identify urinary tract infections (UTIs), as well as liver, kidney, and diabetic issues. This examination can be carried out to assess UTI symptoms during a standard check-up. Furthermore, an increase in the availability of test types coupled with several other businesses working towards creating innovative technology will support the segment's revenue share.
UTI testing market is bifurcated based on the test kit type including laboratory test kits and home test kits. The home test kits segment is anticipated to witness highest CAGR at 5.9% during the forecast period owing to better accuracy. UTI home test kits are designed to detect the presence of urinary tract infections (UTIs) in the comfort of own home. These tests typically use a dipstick or strip that is immersed in a urine sample, and the results are available within minutes. Such benefits offered by the home test kits will drive the segment expansion.
Urinary tract infection testing market is bifurcated based on the application including urethritis, cystitis, and pyelonephritis. The cystitis segment is anticipated to grow over USD 560 million by 2032. Cystitis is a type of urinary tract infection that affects the bladder. It is a common condition, especially among women. However, if the severity worsens, antibiotics might be required. Within three days of taking antibiotics, patients with uncomplicated cystitis typically show signs of improvement in their symptoms. Some people have frequent cystitis, which may necessitate long-term or continuing medical care. Thus, the aforementioned factors will foster the industry landscape.
UTI testing market is segmented by end-use into hospitals, diagnostic laboratories, homecare settings, and others. Hospitals segment dominated the global urinary tract infection testing market accounting for more than 44% business share in 2022 and is estimated to witness significant revenue over USD 450 million by 2032. This is attributable to growing number of people suffering from UTIs across developing countries, rising awareness about urinary tract infection testing, and increasing prevalence of diabetes. Further, increasing disposable spending in developed nations will contribute considerably towards adoption of urinary tract infection testing in homecare settings thereby leading to segment progress.
North America urinary tract infection testing market accounted for more than USD 230 million in 2022 and will grow momentously more than USD 400 million by 2032. The affordability of urinary tract infection testing among the target population base and ongoing technological developments for early detection of UTI are primarily responsible for the regional market growth. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the North America market. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S.
Air Cooled Home Standby Gensets Market Share
Some of the notable key industry players operating in the UTI testing market include
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories
- Danaher Corporation
- ACON Laboratories Inc.
- Cardinal Health Inc.
- Stryker Corporation
- SYSMEX CORPORATION
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- LabCorp (Laboratory Corporation of America Holdings)
- Siemens Healthineers Inc.
These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new type development and launches to strengthen type offerings as well as gain a competitive edge over others.
Urinary Tract Infection Testing Industry News:
- In July 2020, a UTI detection and management kit was released by the urinary health biotechnology company Uqora, Inc. (Pharmavite, LLC). It features the Clarify quick diagnostic tool, which works in homecare and PoC environments. This product launch has resulted in business expansion of the company globally.
- In September 2021, the company launched its at-home UTI testing kit in the UK. The kit, called "Dip UTI," allows people to test for UTIs from the comfort of their own homes using their smartphones. If the test result indicates the presence of a UTI, the user can then share the result with a healthcare professional for further evaluation and treatment.
Urinary tract infection testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Test Type (USD Million)
- Urinalysis
- Urine cultures
- Susceptibility testing
Market, By Test Kit Type (USD Million)
- Laboratory test kits
- Home test kits
Market, By Application (USD Million)
- Urethritis
- Cystitis
- Pyelonephritis
Market, By End-use (USD Million)
- Hospitals
- Diagnostic laboratories
- Homecare settings
- Others
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Poland
- Switzerland
- Norway
- Finland
- Sweden
- Denmark
- The Netherlands
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Indonesia
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Israel
Frequently Asked Questions (FAQ) :